Taiwan FDA registration 8fcabc848d7a5e5f4e6fe2354be865f5

"Sérenowwas" is the intermediary director of Sérigride

TW: “賽瑞諾華斯” 賽瑞格萊德中介導管

Taiwan·Risk Class 2·Cerenovus, Inc.;; CERENOVUS, INC.·Registered Jul 11, 2024 – Jul 11, 2029Active

Registration details

Analysis ID: 8fcabc848d7a5e5f4e6fe2354be865f5
Customs Code: DHA05603724408

Company information

Manufacturer: Cerenovus, Inc.;; CERENOVUS, INC.
Manufacturer Country: Mexico;;United States
Authorized Representative: JOHNSON & JOHNSON MEDICAL TAIWAN LTD.

Product details

Intended Use: Details are as detailed as approved Chinese instructions
Product Type (Level 1): K Neuroscience;; E Cardiovascular Medicine Science
Product Type (Level 2): E.1250 Percutaneous catheters;; K.5600 Neurovascular mechanical clot removal device for the treatment of acute ischemic stroke
Import Information: import

Dates and status

Registration Date: Jul 11, 2024
Expiry Date: Jul 11, 2029

About this record

Access comprehensive regulatory information for "Sérenowwas" is the intermediary director of Sérigride in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8fcabc848d7a5e5f4e6fe2354be865f5 and manufactured by Cerenovus, Inc.;; CERENOVUS, INC.. The authorized representative in Taiwan is JOHNSON & JOHNSON MEDICAL TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.